Skip to main content

Grant Funding Opportunities: 2/27/2015

Weekly Grant Funding Opportunities

Please feel free to send special funding search requests any time (susan_craft@ncbiotech.org).  Grant funding requests are included our regular research and include a fee of $100/hour. Also, let us know if any of your partners have submitted grant applications to funding announcements posted in the weekly grant alert emails.  We would love to hear of their successes!

Visit NCBiotech’s Funding Gateway page to get more information on funding announcements, links to opportunity search databases and grant development tips.

 

Announcements

We will be discontinuing the weekly grants email as of April 1, 2015. We will be updating our Funding Gateway over the next month to provide resources such as links to agencies’ websites and newsletters, and tips for carrying out targeted searches to find opportunities that are most relevant for you or your organization. If you’d like to be added to our monthly e-newsletter about NCBiotech grant programs, please let me know. The library will continue to provide customized reports for funding opportunities on specific topics at our research fee of $100/hour.


 

Upcoming Deadlines

Deadline: 4/15/2015

Agency: Children's Leukemia Research Association

Program: Childhood Leukemia Research Projects

Description: The Children’s Leukemia Research Association, also known as the National Leukemia Research Association, was founded in 1965 to support research efforts dedicated to finding the cause of and a cure for leukemia. To that end, CLRA is seeking applications from investigators for childhood leukemia research projects. Grants of up to $30,000 will be awarded to promising projects focused on isolating the causes of and finding a cure for childhood leukemia. Funding from other sources is permissible, but CLRA funding objectives should not duplicate those of other funding sources.

Award Amount: $30,000.00

Website: www.childrensleukemia.org/researchgrants.html

Eligibility: Any doctor at the Ph.D. or M.D. level involved in finding the causes of and a cure for leukemia is eligible to apply.


 

New Opportunities

Deadline: 5/6/2015 (Pre-application)

Agency: Department of Defense

Program: FY15 Ovarian Cancer Research Program Clinical Translational Award

Description: The intent of the OCRP Clinical Translational Award mechanism is to support translational research addressing high-impact ideas or unmet needs in ovarian cancer. This award supports preclinical and clinical research studies. Clinical trials are not supported by this award mechanism. Although not intended to fund clinical trials, the Clinical Translational Award can also be used to support research projects related to or associated with ongoing or completed clinical trials supported by other funding sources. Preliminary data are required.

Award Amount: Varies

Website: http://cdmrp.army.mil/funding/pa/15ocrpcta_pa.pdf

Eligibility: Restricted


Deadline: 6/9/2015

Agency: National Institutes of Health

Program: Systems Biology and Antibacterial Resistance (U01)

Description: This Funding Opportunity Announcement (FOA) solicits applications that use a multi-disciplinary systems biology approach to study the molecular interaction networks of the pathogen and the host in association with antibacterial resistance or in response to treatment of antibacterial resistant infections. The applications focus must be on bacterial pathogens with established antibacterial resistance. This FOA will not support applications focused on drug-resistant tuberculosis.

Award Amount: Varies

Website: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-14-064.html

Eligibility: State, county or city governments; public and private institutes of higher education; school districts; small businesses; nonprofits; Native American tribal organizations; others


Deadline: 6/16/2015 (LOI due 2 weeks before this date)

Agency: Alzheimer's Drug Discovery Foundation

Program: Program to Accelerate Clinical Trials

Description: The Alzheimer's Drug Discovery Foundation is accepting proposals for clinical trials of innovative drugs to treat Alzheimer's disease. Through its Program to Accelerate Clinical Trials, the foundation will award grants of up to $1.5 million for biomarker-based pilot clinical trials of  Alzheimer drugs at the proof-of-concept phase. The foundation is particularly interested in projects aimed at testing drugs approved for other indications in Alzheimer’s disease, as well as therapies that address energy utilization/mitochondria function, insulin sensitivity, protein degradation/autophagy, ApoE function and cholesterol metabolism, vesicular trafficking, inflammatory pathways, synaptic function/morphology, calcium regulation, myelin changes, ischemia and oxidative stress, vascular injury, and the blood-brain barrier interface.

Award Amount: $1,500,000.00

Website: www.alzdiscovery.org/assets/content/static/2015_PACT_RFP.pdf

Eligibility: Nonprofit academic institutions and for-profit biotechnology companies are eligible to apply.


Deadline: 7/31/2015

Agency: Cutaneous Lymphoma Foundation

Program: Innovative Research Projects

Description: The Cutaneous Lymphoma Foundation is accepting applications from investigators for innovative cutaneous lymphoma research projects. Through its CLARIONS Research Awards Program, the foundation will award two grants of $25,000 each  in support of innovative research aimed at uncovering the causes of cutaneous lymphoma and improving  treatment and quality of life for patients with the disease. Priority will be given to research in the areas of etiology and risk factors, measures of disease impact, translating discoveries into diagnostic and therapeutic advances, optimizing therapies, and improving quality of life.

Award Amount: $25,000

Website: www.clfoundation.org/research/research-awards-program

Eligibility: Investigators at all levels, from clinical and postdoctoral fellows to established investigators, are eligible to apply. Medical students and graduate students are not eligible.


Deadline: 9/18/2015

Agency: National Institutes of Health

Program: Bioengineering Research Partnerships (BRP) R01

Description: This Funding Opportunity Announcement (FOA) encourages bioengineering applications that will accelerate the development and adoption of promising tools and technologies that can address important biomedical research problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing these technologies and engage biomedical researchers or clinicians throughout the project. The goal of the program is to support projects that can realize meaningful solutions within 5-10 years.

Award Amount: Varies

Website: http://grants.nih.gov/grants/guide/pa-files/PAR-14-092.html

Eligibility: State, county or city governments; public and private institutes of higher education; school districts; small businesses; nonprofits; Native American tribal organizations; others

Add new comment

Refresh Type the characters you see in this picture.
Type the characters you see in the picture; if you can't read them, submit the form and a new image will be generated. Not case sensitive.  Switch to audio verification.